-
Part 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM
-
Part 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice
-
Part 1 | Session 8 Plenary session 4 – Obesity and weight management in HF
-
Part 1 | Session 10 Plenary session 5 – Worsening and acute heart failure
-
Part 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence
-
Part 2 | Session 4 Plenary session 7 – Managing comorbidities in HF
-
Part 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place?
-
Part 2 | Session 7 Plenary session 9 – New technologies for HF management
-
Part 2 | Session 8 Plenary session 10 – Special Populations
-
Part 1 | Session 1 Plenary session 1 – Recent guideline updates in HF
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Michael Böhm
Director Internal Medicine Clinic III, Angiology and Intensive Care Medicine
Academic History
Michael Böhm studied medicine from 1977 to 1984 at the Medical School of Hannover (MHH), Germany. During 1979–1981, he completed his doctoral thesis at the Centre for Toxicology and Pharmacology at MHH. He then spent time (1982) at the Tufts University, Boston, USA. Following that, from 1982–1984 he worked as a scientific assistant at the University Hospital Hamburg-Eppendorf (division of general pharmacology). From 1986 to 1993, he trained in internal medicine and cardiology at the Medizinische Klinik I, Klinikum Großhadern, of the Ludwig-Maximilians-Universität München. In 1993 he obtained his habilitation and became assistant professor of internal medicine/cardiology at the Universität zu Köln (University of Cologne). Between 1995 and 2000 he held a C3-Professorship there; in 2000 he was appointed to a C4-Professorship for Internal Medicine with focus on Cardiology/Angiology at the Saarland University, Homburg/Saar, Germany — at which time he became…
Frieder Braunschweig
Director of Cardiology
Prof Frieder Braunschweig is the Director of Cardiology at Karolinska University Hospital, Stockholm, SE and a Professor at Karolinska Institutet in Stockholm, SE.
His clinical focus areas include invasive electrophysiology, cardiac pacing, heart failure and sports cardiology.
John JV McMurray
Professor of Cardiology
Prof John McMurray is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. A graduate of Manchester University, Prof McMurray completed postgraduate research at the University of Dundee.
Prof McMurray is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences.
Gianluigi Savarese
Associate Professor of Cardiology
Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden.
Prof Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology.
Prof Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Prof Savarese completed his PhD at the Karolinska Institutet in 2018.
Prof Savarese has…
Marianna Adamo
Inteventional Cardiologist
Prof Marianna Adamo is an interventional cardiologist and heart failure physician, and Associate Professor at the University of Brescia, Italy. Her clinical and research interests focus on structural heart interventions, including transcatheter aortic valve implantation (TAVI), with particular emphasis on patient selection, procedural optimisation, and long-term outcomes. Prof Adamo is actively involved in international research collaborations and frequently contributes to leading cardiology congresses and publications.
Comments